362 related articles for article (PubMed ID: 21118401)
1. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.
Satoh J; Kino Y; Motohashi N; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043
[TBL] [Abstract][Full Text] [Related]
3. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
Satoh J
Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Syk expression is enhanced in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Saito Y; Arima K
Neuropathology; 2012 Apr; 32(2):149-57. PubMed ID: 21981270
[TBL] [Abstract][Full Text] [Related]
5. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
[TBL] [Abstract][Full Text] [Related]
6. LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains.
Satoh J; Motohashi N; Kino Y; Ishida T; Yagishita S; Jinnai K; Arai N; Nakamagoe K; Tamaoka A; Saito Y; Arima K
Orphanet J Rare Dis; 2014 May; 9():68. PubMed ID: 24886140
[TBL] [Abstract][Full Text] [Related]
7. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation.
Solje E; Hartikainen P; Valori M; Vanninen R; Tiihonen J; Hakola P; Tienari PJ; Remes AM
Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676
[TBL] [Abstract][Full Text] [Related]
8. A Shotgun Proteomic Platform for a Global Mapping of Lymphoblastoid Cells to Gain Insight into Nasu-Hakola Disease.
De Palma A; Agresta AM; Viglio S; Rossi R; D'Amato M; Di Silvestre D; Mauri P; Iadarola P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576123
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease pathology in Nasu-Hakola disease brains.
Satoh JI; Kino Y; Yanaizu M; Saito Y
Intractable Rare Dis Res; 2018 Feb; 7(1):32-36. PubMed ID: 29552443
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis.
Errichiello E; Dardiotis E; Mannino F; Paloneva J; Mattina T; Zuffardi O
Front Immunol; 2019; 10():1685. PubMed ID: 31396216
[TBL] [Abstract][Full Text] [Related]
11. Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease.
Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
Intractable Rare Dis Res; 2019 May; 8(2):120-128. PubMed ID: 31218162
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.
Satoh J; Shimamura Y; Tabunoki H
Cell Mol Neurobiol; 2012 Apr; 32(3):337-43. PubMed ID: 22080356
[TBL] [Abstract][Full Text] [Related]
13. Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family.
Numasawa Y; Yamaura C; Ishihara S; Shintani S; Yamazaki M; Tabunoki H; Satoh JI
Eur J Neurol; 2011 Sep; 18(9):1179-83. PubMed ID: 21834902
[TBL] [Abstract][Full Text] [Related]
14. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
[TBL] [Abstract][Full Text] [Related]
15. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology.
Kaneko M; Sano K; Nakayama J; Amano N
Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450
[TBL] [Abstract][Full Text] [Related]
16. Human early-onset dementia caused by DAP12 deficiency reveals a unique signature of dysregulated microglia.
Zhou Y; Tada M; Cai Z; Andhey PS; Swain A; Miller KR; Gilfillan S; Artyomov MN; Takao M; Kakita A; Colonna M
Nat Immunol; 2023 Mar; 24(3):545-557. PubMed ID: 36658241
[TBL] [Abstract][Full Text] [Related]
17. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
[TBL] [Abstract][Full Text] [Related]
18. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.
Sessa G; Podini P; Mariani M; Meroni A; Spreafico R; Sinigaglia F; Colonna M; Panina P; Meldolesi J
Eur J Neurosci; 2004 Nov; 20(10):2617-28. PubMed ID: 15548205
[TBL] [Abstract][Full Text] [Related]
19. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
Piccio L; Buonsanti C; Mariani M; Cella M; Gilfillan S; Cross AH; Colonna M; Panina-Bordignon P
Eur J Immunol; 2007 May; 37(5):1290-301. PubMed ID: 17407101
[TBL] [Abstract][Full Text] [Related]
20. Microglia express gamma-interferon-inducible lysosomal thiol reductase in the brains of Alzheimer's disease and Nasu-Hakola disease.
Satoh JI; Kino Y; Yanaizu M; Ishida T; Saito Y
Intractable Rare Dis Res; 2018 Nov; 7(4):251-257. PubMed ID: 30560017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
